Chemistry:10,11-Seco-LSD

From HandWiki

10,11-Seco-LSD is a partial lysergamide and cyclized tryptamine related to lysergic acid diethylamide (LSD).[1] It is the seco analogue of LSD in which the bond between the 10 and 11 positions of the ergoline ring system has been broken.[1] 10,11-Seco-LSD was described in a patent by David E. Olson and colleagues at Delix Therapeutics in 2021.[1] Its pharmacology was not described.[1]

LSD (left) and 10,11-seco-LSD (right) chemical structures.

See also

  • Partial lysergamide
  • Seco-LSD
  • Secoergoline
  • NDTDI (8,10-seco-LSD)
  • DEIMDHPCA (3,5-seco-LSD)

References

  1. ↑ 1.0 1.1 1.2 1.3 Olson DE, Dunlap LM, Wagner F, Chytil M, Powell NE, "Ergoline-like compounds for promoting neural plasticity", WO patent 2021076572, published 22 April 2021, assigned to Delix Therapeutics, Inc.and The Regents of the University of California





Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:10,11-Seco-LSD&oldid=4242974"